CIMAB (Centro de Inmunología Molecular y Bioproductos)

CIMAB (Centro de Inmunología Molecular y Bioproductos) is a scientific research organization dedicated to developing advanced medical treatments, primarily focusing on immunology and biopharmaceuticals. They create innovative medicines such as vaccines, antibodies, and other biological products to improve healthcare. CIMAB conducts research, develops new therapies, and collaborates with international partners to address health challenges. Their work aims to provide effective, accessible solutions for diseases, contributing to better patient outcomes and advancing medical science through cutting-edge biotechnological research.